Resistance on Antithrombotic Drugs in Ischemic Heart Disease

NCT00742430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2012-02-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether aspirin and clopidogrel resistance measured with Multiplate function analyser has a good correlation with incidence of major adverse cardiac events in patients with coronary artery disease (CAD).

Conditions

Interventions

PROCEDURE

PCI

percutaneous coronary intervention in stable coronary artery disease

Sponsors & Collaborators

  • University of Zagreb

    lead OTHER

Principal Investigators

  • Davor Milicic, prof.dr.sc. · Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia

  • Bosko Skoric, dr. · Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Completion
2011-08-31

Countries

  • Croatia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00742430 on ClinicalTrials.gov